111 related articles for article (PubMed ID: 32831339)
1. Proposal for the management of COVID-19-associated coagulopathy in children.
Ávila-Castro D; Ortiz-Torres G; Sánchez-Jara B; Valle-Cárdenas T; Aquino-Fernández E; González-Ávila AI; Majluf-Cruz A
Gac Med Mex; 2020; 156(4):344-353. PubMed ID: 32831339
[TBL] [Abstract][Full Text] [Related]
2. A proposal for the management of COVID-19-induced coagulopathy in adults.
Ignacio-Ibarra G; García-Lee MT; González-Ávila AI; García-Chávez J; Guzmán-Chores L; Cruz CL; Lugo-García Y; Juárez-Lara J; García-Vázquez M; Madera-Maldonado CE; Ramos-Peñafiel CO; Majluf-Cruz A
Gac Med Mex; 2021; 157(2):201-206. PubMed ID: 34270538
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated coagulopathy.
Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
[TBL] [Abstract][Full Text] [Related]
4. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
[TBL] [Abstract][Full Text] [Related]
5. [Coagulopathy and COVID-19. Recommendations for a changing reality].
Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Associated Coagulopathy and Thrombotic Complications.
Mezalek ZT; Khibri H; Ammouri W; Bouaouad M; Haidour S; Harmouche H; Maamar M; Adnaoui M
Clin Appl Thromb Hemost; 2020; 26():1076029620948137. PubMed ID: 32795186
[TBL] [Abstract][Full Text] [Related]
7. [Coagulopathy in COVID-19: pathophysiology].
Pierini S; Incampo E; Bokor D; Dadone V; Ornaghi M; Zanini F; Gentile F; Mancarella S
G Ital Cardiol (Rome); 2020 Jul; 21(7):483-488. PubMed ID: 32555563
[TBL] [Abstract][Full Text] [Related]
8. Heparin as a therapy for COVID-19: current evidence and future possibilities.
Hippensteel JA; LaRiviere WB; Colbert JF; Langouët-Astrié CJ; Schmidt EP
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L211-L217. PubMed ID: 32519894
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 infection and thrombosis.
Srivastava S; Garg I; Bansal A; Kumar B
Clin Chim Acta; 2020 Nov; 510():344-346. PubMed ID: 32712049
[TBL] [Abstract][Full Text] [Related]
10. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
Mazzeffi M; Chow JH; Amoroso A; Tanaka K
Anesth Analg; 2020 Sep; 131(3):690-693. PubMed ID: 32541255
[No Abstract] [Full Text] [Related]
12. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
Boccia M; Aronne L; Celia B; Mazzeo G; Ceparano M; D'Agnano V; Parrella R; Valente T; Bianco A; Perrotta F
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425013
[TBL] [Abstract][Full Text] [Related]
13. Focus on coronavirus disease 2019 associated coagulopathy.
Yang XH; Li RR; Sun RH; Liu J; Chen DC
Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
[No Abstract] [Full Text] [Related]
14. Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.
Assimakopoulos SF; Seintis F; Marangos M
Med Hypotheses; 2020 Oct; 143():109926. PubMed ID: 32485316
[No Abstract] [Full Text] [Related]
15. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
Bhattacharjee S; Banerjee M; Pal R
Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 infection in children with febrile neutropenia.
Flores V; Miranda R; Merino L; González C; Serrano C; Solano M; Herrera J; González P; Ruiz G; Saldaña R; Cárdenas A; Chávez-Aguilar LA
Ann Hematol; 2020 Aug; 99(8):1941-1942. PubMed ID: 32529285
[No Abstract] [Full Text] [Related]
19. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
Zhai Z; Li C; Chen Y; Gerotziafas G; Zhang Z; Wan J; Liu P; Elalamy I; Wang C;
Thromb Haemost; 2020 Jun; 120(6):937-948. PubMed ID: 32316065
[TBL] [Abstract][Full Text] [Related]
20. Left gonadal vein thrombosis in a patient with COVID-19-associated coagulopathy.
Veyseh M; Pophali P; Jayarangaiah A; Kumar A
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32900740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]